Trial Profile
Timing of Initiation of Low Molecular Weight Heparin Administration in Pregnant Women With Antiphospholipid Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2017
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Antiphospholipid syndrome
- Focus Therapeutic Use
- 03 Jun 2017 Status changed from recruiting to completed.
- 18 Nov 2016 Planned End Date changed from 1 Dec 2016 to 1 Mar 2017.
- 18 Nov 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Jan 2017.